ChemBK
Home
Product Category
Suppliers
Search
3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
Request for Quotation
Zofluza intermediate
CAS: 1370250-39-7
Molecular Formula: C14H10F2O2S
Home
Product Category
pharmaceutical intermediates
API intermediate
3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione -
Names and Identifiers
Name
Zofluza intermediate
Synonyms
BM-A60
Zofluza intermediate
Baloxavir Impurity 3
Baloxavir marboxil intermediate
7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
CAS
1370250-39-7
3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione -
Physico-chemical Properties
Molecular Formula
C14H10F2O2S
Molar Mass
280.2898064
Density
1.43±0.1 g/cm3(Predicted)
Boling Point
575.3±60.0 °C(Predicted)
pKa
-1.40±0.40(Predicted)
Storage Condition
2-8℃
Use
Uses This product is used as an intermediate for Barlosavir.
View 3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione structural formula
Supplier List
Hubei YoungXin Pharmaceutical Tech Co.,Ltd.
Spot supply
Product Name:
Baloxavir Impurity 3
Visit Supplier Webpage
Request for quotation
CAS: 1370250-39-7
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052
Wechat: 15671228036
Hubei YoungXin Pharmaceutical Tech Co.,Ltd.
Spot supply
Product Name:
Baloxavir Impurity 3
Visit Supplier Webpage
Request for quotation
CAS: 1370250-39-7
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052
Wechat: 15671228036
View History
3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
Home
Product Category
© 2015, 2023 ChemBK.com All Rights Reserved | Build: 20230617001